Metraipolis › archive › dc_aa7251107fbf

Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs — Europe PMC PMID:39623907

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/39623907
DOI
10.1017/s026646232400062x
License (as archived)
solo-consultazione
Archived
2026-10-08T00:00:12.093Z
SHA-256 of the archived text
7b83cf4737303ea7683691187ccbd394cc5ed517e548ffd72eef33c6c6d3e14e
Stable URL of this page
https://metraipolis.com/documento/dc_aa7251107fbf

How to cite

Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs — Europe PMC PMID:39623907 — Europe PMC (en), https://europepmc.org/article/MED/39623907 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa7251107fbf (Metraipolis archive dc_aa7251107fbf, sha256 7b83cf4737303ea7683691187ccbd394cc5ed517e548ffd72eef33c6c6d3e14e)
BibTeX
@misc{dcaa7251107fbf,
  title = {Results of health technology assessments of orphan drugs in Germany-lack of added benefit, evidence gaps, and persisting unmet medical needs — Europe PMC PMID:39623907},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/39623907},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa7251107fbf; sha256 7b83cf4737303ea7683691187ccbd394cc5ed517e548ffd72eef33c6c6d3e14e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/39623907. Agents can read the archived copy with the MCP tool read_document.